Luminar Technologies Valuation
Is LAZR * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of LAZR * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate LAZR *'s fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate LAZR *'s fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for LAZR *?
Other financial metrics that can be useful for relative valuation.
What is LAZR *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$748.56m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 16x |
Enterprise Value/EBITDA | -2.1x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does LAZR *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 1.3x | ||
NEMAK A Nemak S. A. B. de C. V | 0.1x | 2.8% | Mex$8.6b |
GISSA A Grupo Industrial Saltillo. de | 0.4x | n/a | Mex$6.8b |
688155 Shanghai SK Automation Technology | 2.3x | 24.8% | CN¥5.5b |
HSAI Hesai Group | 2.6x | 22.7% | US$662.2m |
LAZR * Luminar Technologies | 10.7x | 46.1% | Mex$748.6m |
Price-To-Sales vs Peers: LAZR * is expensive based on its Price-To-Sales Ratio (10.7x) compared to the peer average (1.3x).
Price to Earnings Ratio vs Industry
How does LAZR *'s PE Ratio compare vs other companies in the Global Auto Components Industry?
Price-To-Sales vs Industry: LAZR * is expensive based on its Price-To-Sales Ratio (10.7x) compared to the Global Auto Components industry average (0.9x).
Price to Sales Ratio vs Fair Ratio
What is LAZR *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 10.7x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate LAZR *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$26.65 | Mex$90.12 +238.2% | 57.4% | Mex$187.20 | Mex$20.42 | n/a | 12 |
Apr ’25 | n/a | Mex$91.27 0% | 51.8% | Mex$182.95 | Mex$24.95 | n/a | 12 |
Mar ’25 | n/a | Mex$114.86 0% | 77.2% | Mex$340.96 | Mex$25.57 | n/a | 12 |
Feb ’25 | n/a | Mex$147.37 0% | 71.1% | Mex$344.72 | Mex$34.47 | n/a | 12 |
Jan ’25 | n/a | Mex$160.04 0% | 62.4% | Mex$344.18 | Mex$51.63 | n/a | 12 |
Dec ’24 | Mex$45.50 | Mex$160.62 +253.0% | 60.1% | Mex$346.27 | Mex$51.94 | n/a | 13 |
Nov ’24 | n/a | Mex$199.01 0% | 45.9% | Mex$358.08 | Mex$62.66 | n/a | 13 |
Oct ’24 | Mex$77.00 | Mex$198.92 +158.3% | 43.4% | Mex$350.63 | Mex$78.89 | n/a | 13 |
Sep ’24 | n/a | Mex$202.96 0% | 40.1% | Mex$341.83 | Mex$76.91 | n/a | 12 |
Aug ’24 | Mex$121.00 | Mex$208.28 +72.1% | 39.9% | Mex$334.36 | Mex$75.23 | n/a | 12 |
Jul ’24 | n/a | Mex$216.06 0% | 41.9% | Mex$351.55 | Mex$79.10 | n/a | 12 |
Jun ’24 | Mex$118.00 | Mex$216.06 +83.1% | 41.9% | Mex$351.55 | Mex$79.10 | n/a | 12 |
May ’24 | n/a | Mex$240.48 0% | 41.4% | Mex$434.21 | Mex$81.41 | n/a | 12 |
Apr ’24 | n/a | Mex$247.98 0% | 40.8% | Mex$446.36 | Mex$92.99 | n/a | 12 |
Mar ’24 | Mex$170.00 | Mex$233.83 +37.5% | 40.8% | Mex$434.47 | Mex$90.51 | n/a | 12 |
Feb ’24 | Mex$127.00 | Mex$241.31 +90.0% | 40.2% | Mex$451.28 | Mex$94.02 | n/a | 12 |
Jan ’24 | Mex$98.50 | Mex$258.64 +162.6% | 38.0% | Mex$474.45 | Mex$138.38 | n/a | 12 |
Dec ’23 | n/a | Mex$273.24 0% | 47.9% | Mex$585.51 | Mex$156.14 | Mex$45.50 | 13 |
Nov ’23 | n/a | Mex$283.66 0% | 46.7% | Mex$591.60 | Mex$138.04 | n/a | 13 |
Oct ’23 | n/a | Mex$300.61 0% | 45.4% | Mex$611.41 | Mex$163.04 | Mex$77.00 | 12 |
Sep ’23 | Mex$171.00 | Mex$276.82 +61.9% | 34.8% | Mex$480.78 | Mex$160.26 | n/a | 11 |
Aug ’23 | n/a | Mex$350.70 0% | 51.9% | Mex$759.22 | Mex$184.68 | Mex$121.00 | 11 |
Jul ’23 | Mex$120.00 | Mex$374.44 +212.0% | 43.7% | Mex$741.18 | Mex$180.29 | n/a | 13 |
Jun ’23 | Mex$200.00 | Mex$373.95 +87.0% | 41.4% | Mex$728.22 | Mex$177.13 | Mex$118.00 | 13 |
May ’23 | Mex$268.00 | Mex$463.09 +72.8% | 35.3% | Mex$760.02 | Mex$240.01 | n/a | 13 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.